Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HA-IC/BPSPilot: Hyaluronic Acid Injection for Interstitial Cystitis
NCT07658118Phase 1Not yet recruiting
- Sponsor
- Sverdlovsk Regional Clinical Hospital No.1
- Start
- Jul 2026
- Primary completion
- Dec 2026
01
Overview
Phase 1, open-label, single-arm trial of hyaluronic acid in interstitial cystitis (IC), sponsored by Sverdlovsk Regional Clinical Hospital No.1. Primary endpoint: Treatment-Related Adverse Events at 30 days. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
hyaluronic acid
03
Conditions
interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT07658118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07658118.